Switzerland · Delayed Price · Currency is CHF Medartis Holding AG Statistics
Total Valuation
SWX:MED has a market cap or net worth of CHF 1.12 billion. The enterprise value is 1.30 billion.
| Market Cap | 1.12B |
| Enterprise Value | 1.30B |
Important Dates
The last earnings date was Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:MED has 12.45 million shares outstanding. The number of shares has increased by 0.56% in one year.
| Current Share Class | 12.45M |
| Shares Outstanding | 12.45M |
| Shares Change (YoY) | +0.56% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 48.93% |
| Owned by Institutions (%) | 14.21% |
| Float | 4.06M |
Valuation Ratios
The trailing PE ratio is 75.14 and the forward PE ratio is 51.07.
| PE Ratio | 75.14 |
| Forward PE | 51.07 |
| PS Ratio | 3.65 |
| PB Ratio | 3.98 |
| P/TBV Ratio | 31.59 |
| P/FCF Ratio | 195.95 |
| P/OCF Ratio | 32.99 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 36.23, with an EV/FCF ratio of 227.66.
| EV / Earnings | 87.31 |
| EV / Sales | 4.24 |
| EV / EBITDA | 36.23 |
| EV / EBIT | 146.51 |
| EV / FCF | 227.66 |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.74.
| Current Ratio | 3.36 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | 5.76 |
| Debt / FCF | 36.22 |
| Interest Coverage | 2.58 |
Financial Efficiency
Return on equity (ROE) is 5.75% and return on invested capital (ROIC) is 1.32%.
| Return on Equity (ROE) | 5.75% |
| Return on Assets (ROA) | 1.03% |
| Return on Invested Capital (ROIC) | 1.32% |
| Return on Capital Employed (ROCE) | 1.62% |
| Weighted Average Cost of Capital (WACC) | 9.20% |
| Revenue Per Employee | 215,022 |
| Profits Per Employee | 10,450 |
| Employee Count | 1,337 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 0.73 |
Taxes
In the past 12 months, SWX:MED has paid 7.05 million in taxes.
| Income Tax | 7.05M |
| Effective Tax Rate | 31.10% |
Stock Price Statistics
The stock price has increased by +6.75% in the last 52 weeks. The beta is 1.17, so SWX:MED's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +6.75% |
| 50-Day Moving Average | 85.45 |
| 200-Day Moving Average | 83.49 |
| Relative Strength Index (RSI) | 55.89 |
| Average Volume (20 Days) | 4,749 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:MED had revenue of CHF 307.05 million and earned 14.92 million in profits. Earnings per share was 1.20.
| Revenue | 307.05M |
| Gross Profit | 237.89M |
| Operating Income | 8.89M |
| Pretax Income | 22.66M |
| Net Income | 14.92M |
| EBITDA | 29.08M |
| EBIT | 8.89M |
| Earnings Per Share (EPS) | 1.20 |
Balance Sheet
The company has 25.81 million in cash and 207.26 million in debt, with a net cash position of -181.46 million or -14.58 per share.
| Cash & Cash Equivalents | 25.81M |
| Total Debt | 207.26M |
| Net Cash | -181.46M |
| Net Cash Per Share | -14.58 |
| Equity (Book Value) | 281.87M |
| Book Value Per Share | 22.65 |
| Working Capital | 147.04M |
Cash Flow
In the last 12 months, operating cash flow was 34.00 million and capital expenditures -28.27 million, giving a free cash flow of 5.72 million.
| Operating Cash Flow | 34.00M |
| Capital Expenditures | -28.27M |
| Depreciation & Amortization | 20.19M |
| Net Borrowing | 34.58M |
| Free Cash Flow | 5.72M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 77.48%, with operating and profit margins of 2.90% and 4.86%.
| Gross Margin | 77.48% |
| Operating Margin | 2.90% |
| Pretax Margin | 7.38% |
| Profit Margin | 4.86% |
| EBITDA Margin | 9.47% |
| EBIT Margin | 2.90% |
| FCF Margin | 1.86% |
Dividends & Yields
SWX:MED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.56% |
| Shareholder Yield | -0.56% |
| Earnings Yield | 1.33% |
| FCF Yield | 0.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for SWX:MED is 101.67, which is 12.84% higher than the current price. The consensus rating is "Buy".
| Price Target | 101.67 |
| Price Target Difference | 12.84% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 19.02% |
| EPS Growth Forecast (3Y) | 83.86% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:MED has an Altman Z-Score of 2.72 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.72 |
| Piotroski F-Score | 5 |